Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
Conditions: Coronary Heart Disease; Diastolic Dysfunction Intervention: Drug: Trimetazidine Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials